Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Diabetes Mellitus, Type 1
Interventions: Pops! One personalized mobile platform; Device
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: 10 Years to 25 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Facial Hyperpigmentation
Interventions: Test cosmetic product; Drug
Lead sponsor: Kayuraeffect, LLP; Industry
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Miami Lakes, Florida • New York, New York

Conditions: Dementia With Lewy Bodies, Parkinson Disease Dementia, Healthy Controls
Interventions: Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims, Plasma biomarkers, Galantamine HBr extended-release 8mg capsules (8mg ER).; Procedure · Diagnostic Test · Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 50 Years to 89 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Tobacco Use Disorder
Interventions: ModafinilNicotine Replacement Therapy, Modafinil; Drug
Lead sponsor: Catherine Martin, MD; Other
Eligibility: 16 Years to 40 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Overweight and Obesity
Interventions: SMART 2.0; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 35 Years
Enrollment: 638 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Asthma, Asthma Attack
Interventions: ASTHMAXcel ED Application; Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Exudative Retinal Detachment and Uveal Melanoma
Interventions: Dexamethasone intravitreal implant; Drug
Lead sponsor: Ivana K. Kim; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer, Anxiety
Interventions: Health Education Program, CBT Mobile Application; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neck Pain
Interventions: Cervical and thoracic mobilization, cervical and thoracic manipulation; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Solon, Ohio • Havertown, Pennsylvania

Conditions: Non Small Cell Lung Cancer, Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Eyelash Hypotrichosis, Alopecia Areata
Interventions: bimatoprost ophthalmic solution 0.03%, Vehicle Sterile Solution; Drug
Lead sponsor: Allergan; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Severe Maternal Morbidity
Interventions: Maternal Health Education Resources, Prenatal Telehealth Visits, Postpartum Telehealth Visits, Home Blood Pressure Monitor, Fitbit; Other · Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 674 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Best Practice, Interview, Survey Administration, Virtual Reality; Other · Procedure
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Nicotine Dependence
Interventions: mSMART; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Menopause, Estrogen Deficiency, Aging, Adiposity
Interventions: Degarelix, Transdermal Estradiol Patch, Transdermal Placebo Patch; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Amyotrophic Lateral Sclerosis
Interventions: PowerLung trainer, Micro Mouth Pressure Meter, Pulmonary Function Testing, Videofluoroscopic swallowing study, Swallowing Quality of Life Questionnaire, Iowa Oral Pressure Instrument, Capsaicin; Device · Procedure · Other + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Traumatic Brain Injury
Interventions: Constraint-Induced Movement Therapy (CIMT), Lakeshore Enriched Fitness Training (LEFT), standard Transfer Package (sTP), enhanced Transfer Package (eTP); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 90 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Neurofibromatosis Type 1, Reading Disabilities
Interventions: Tutoring Program I, Tutoring Program II; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrophy of Vagina, Menopause, Dyspareunia (Female)
Interventions: Vagifem, Replens, Placebo tablet, Placebo gel; Drug · Device · Other
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Chronic Low-back Pain
Interventions: PainGuide, MBSR, PT and exercise, Self -administered acupressure, Duloxetine, Pro-Diary monitor; Behavioral · Device · Drug
Lead sponsor: University of Michigan; Other
Eligibility: 25 Years to 70 Years
Enrollment: 494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Sunscreening Agents
Interventions: BAY987517, Sunscreen Lotion (Y65-110); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Blood Loss
Interventions: Hemostatic Matrix; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: Not listed
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Congestive Heart Failure
Interventions: BodyPort, Noom, Conversa; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Depression, Anxiety, Transition
Interventions: Adapted Teens Achieving Mastery over Stress (TEAMS) Treatment, Adapted Teens Achieving Mastery over Stress (TEAMS) Prevention, Adapted Competent Adulthood Transition with Cognitive-behavioral & Interpersonal Training (CATCH-IT), Strengthening Families, Virtual psycho-educational discussion groups for caregivers and participants, Maternal Child Health Bureau (MCHB) Care Coordination; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 13 Years to 20 Years
Enrollment: 780 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Pediatrics Owning Performance Study

Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents

SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults

ASTHMAXcel Emergency Department Study

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Mobile App of CBT for Anxiety and Cancer

Cervical and Upper Thoracic Mobilization and Manipulation for Mechanical Neck Pain

Study of Use of CTC in NSCLC

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

MOMs Chat and Care Study

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

Cardiometabolic Consequences of the Loss of Ovarian Function

Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)

The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment

Neurobiology and Treatment of Reading Disability in NF-1

The Vaginal Health Trial

The Back Pain Consortium Research Program Study

Supervised Outdoor-Use Test For Sunscreen Products in Adults

The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery

Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure

BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental Disabilities (IDD)